Aminopeptidase N Ligand (CD13) NGR Peptide

Send Inquiry
Aminopeptidase N Ligand (CD13) NGR Peptide
Details
•Product Name: Aminopeptidase N Ligand (CD13) NGR peptide
•CAS No.: 760947-20-4
•Synonyms: NGR peptide, cNGR, Cyclo(CNGRCG)
•Sequence: Cyclo(Cys-Asn-Gly-Arg-Cys-Gly) (Cyclo(CNGRCG)), disulfide-cyclized hexapeptide
•Length: 6 amino acids (cyclic peptide)
•Molecular Formula: C₂₀H₃₄N₁₀O₈S₂
•Molecular Weight: 606.68 Da
•Purity: HPLC ≥95%
Related Documents: COA/MS/HPLC Report, Peptide Solubility and Storage Guide
Category
Drug Delivery Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of aminopeptidase n ligand (cd13) ngr peptide in China, also supports custom service. Welcome to wholesale bulk high quality aminopeptidase n ligand (cd13) ngr peptide from our factory. Contact us for more details.

 

Description Aminopeptidase N Ligand (CD13) NGR peptide (CAS: 760947-20-4) is a disulfide-cyclized hexapeptide with the sequence Cyclo(Cys-Asn-Gly-Arg-Cys-Gly) (Cyclo(CNGRCG)), where a disulfide bond is formed between the two cysteine residues, maintaining the peptide in a cyclic conformation. Its core NGR (Asn-Gly-Arg) motif is a tumor vasculature-targeting peptide that specifically binds to a specific isoform of aminopeptidase N (APN/CD13). CD13/APN is a zinc-dependent transmembrane ectopeptidase highly expressed on the surface of tumor vascular endothelial cells, but not expressed or expressed at low levels in normal quiescent endothelial cells, making it an important marker and target for tumor angiogenesis. The binding of NGR peptide to CD13 is conformation-dependent, with the cyclic form (CNGRCG) exhibiting significantly higher binding affinity and stability than the linear form. Upon binding, the NGR peptide can be internalized through receptor-mediated endocytosis, enabling intracellular drug delivery. The tumor vasculature selectivity of NGR peptide makes it an important tool for tumor-targeted therapy and diagnosis, widely used for: (1) targeted delivery of chemotherapeutic drugs (e.g., doxorubicin, daunorubicin), pro-apoptotic peptides, cytokines (e.g., TNF-α), and imaging agents (e.g., ⁹⁹ᵐTc, ⁶⁸Ga, fluorescent dyes) to tumor vasculature; (2) tumor optical imaging, SPECT/PET imaging, and early diagnosis; (3) construction of NGR-modified nanoparticles, liposomes, and hydrogels; (4) basic research on the role of CD13 receptor in angiogenesis. Cyclic NGR peptide is an important tool for developing novel cancer-targeted therapies and diagnostic methods.

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Aminopeptidase N Ligand (CD13) NGR peptide CD13-targeted NGR peptide; tumor vascular targeting tripeptide Tumor vascular targeting, CD13 ligand, targeted drug delivery, tumor imaging Asn-Gly-Arg tripeptide; specifically binds aminopeptidase N (CD13) overexpressed on tumor vascular endothelium, mediating targeted enrichment of drugs and imaging agents C₁₁H₂₁N₅O₄ 287.16 ~287.3 Acetate 3

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-NGR003 White powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. Soluble in water, dilute acetic acid and PBS. Optimal CD13-binding activity at physiological pH; conformational change and binding activity loss under strong acid/base. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-NGR003 NGR tripeptide targets CD13/aminopeptidase N for tumor vascular targeted delivery NGR peptide is a classic tumor vascular targeting ligand. It specifically binds aminopeptidase N (CD13) overexpressed on tumor neovascular endothelial cells, mediating targeted enrichment of conjugated chemotherapeutics, toxins and imaging agents in tumor vascular areas, enhancing efficacy and reducing systemic side effects. It is also used for tumor vascular imaging and targeted drug carrier development. Tumor targeted therapy, tumor vascular imaging, targeted drug development, vascular biology research, antibody-drug conjugates CD13 (aminopeptidase N); receptor-mediated endocytosis; tumor vascular targeted enrichment

 

 

 

 

Hot Tags: aminopeptidase n ligand (cd13) ngr peptide, China aminopeptidase n ligand (cd13) ngr peptide manufacturers, suppliers, factory, 651328-78-8, CAS 203716 10 3, CAS 395069 92 8, drug delivery peptides, HIV 1 Tat Protein Peptide 47 57 , Tetralysine

Send Inquiry